Open Access. Powered by Scholars. Published by Universities.®
- Institution
- Keyword
-
- AB1534 (1)
- AB1860 (1)
- AB2193 (1)
- AB2342 (1)
- AB2384 (1)
-
- AB2416 (1)
- AB2499 (1)
- AB2643 (1)
- AB2674 (1)
- AB2863 (1)
- AB2941 (1)
- AB2985 (1)
- AB3087 (1)
- AB315 (1)
- AB595 (1)
- ADR (1)
- African American farmers (1)
- Animal Feeding Operations (1)
- Assisted reproductive technology law & policy (1)
- Bioethics (1)
- Biologics Price Competition and Innovation Act of 2009 (1)
- Biopharmaceuticals (1)
- Biosimilar Pharmaceuticals (1)
- Black Belt (1)
- CAFO (1)
- Case law (1)
- Civil litigation (1)
- Concentrated Animal Feeding Operations (1)
- Contract law (1)
- Dispute resolution (1)
- Publication
- Publication Type
Articles 1 - 7 of 7
Full-Text Articles in Entire DC Network
... Because "Yes" Actually Means "No": A Personalized Prescriptive To Reactualize Informed Consent In Dispute Resolution
Marquette Law Review
None.
Department Of Managed Health Care, Jennifer Pardue, J. D. Fellmeth
Department Of Managed Health Care, Jennifer Pardue, J. D. Fellmeth
California Regulatory Law Reporter
No abstract provided.
Cafos: Plaguing North Carolina Communities Of Color, Christine Ball-Blakely
Cafos: Plaguing North Carolina Communities Of Color, Christine Ball-Blakely
Sustainable Development Law & Policy
No abstract provided.
The Biologics Price Competition And Innovation Act: Is A Generic Market For Biologics Attainable?, Kasey E. Koballa
The Biologics Price Competition And Innovation Act: Is A Generic Market For Biologics Attainable?, Kasey E. Koballa
William & Mary Business Law Review
The Biologics Price Competition and Innovation Act of 2009 (BPCIA) provides an abbreviated approval pathway for biological therapeutic products shown to be biosimilar to an FDA-approved biological reference product. The BPCIA purported to reduce the price of biologics while promoting innovation. In two recent cases, the Federal Circuit interpreted a key provision of the BPCIA requiring an applicant to provide the reference product sponsor with notice 180 days before marketing the product. The Federal Circuit’s interpretation extends the exclusivity period already provided for the reference product sponsor, deterring innovation and price reduction. Thus, the Supreme Court granted certiorari in one …
2017 Annual Survey: Recent Developments In Sports Law, Jordan Lysiak, Katherine Hampel
2017 Annual Survey: Recent Developments In Sports Law, Jordan Lysiak, Katherine Hampel
Marquette Sports Law Review
None
Baby M Turns 30: The Law And Policy Of Surrogate Motherhood, Eric A. Feldman
Baby M Turns 30: The Law And Policy Of Surrogate Motherhood, Eric A. Feldman
All Faculty Scholarship
This article marks the 30th anniversary of the Supreme Court of New Jersey’s Baby M decision by offering a critical analysis of surrogacy policy in the United States. Despite fundamental changes in both science and society since the case was decided, state courts and legislatures remain bitterly divided on the legality of surrogacy. In arguing for a more uniform, permissive legal posture toward surrogacy, the article addresses five central debates in the surrogacy literature.
First, should the legal system accommodate those seeking conception through surrogacy, or should it prohibit such arrangements? Second, if surrogacy is permitted, what steps can be …
Bio-Property Contracts In A New Ecosystem: Genetic Resources Access And Benefit Sharing, Mariko Kageyama
Bio-Property Contracts In A New Ecosystem: Genetic Resources Access And Benefit Sharing, Mariko Kageyama
Washington Journal of Law, Technology & Arts
The Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their Utilization to the Convention on Biological Diversity presents a relatively new international legal framework. Although the United States is not currently bound by this legal instrument, its impact may be felt in the life sciences innovation sector and beyond. Transnational implementation mechanisms for the Nagoya Protocol have a combination of property law and contract law as their theoretical underpinning. Stakeholders who are entering into an agreement with their foreign counterparts should honor the Access and Benefit-Sharing scheme as well as domestic …